Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Garrison LP Jr."'
Autor:
Morden NE (AUTHOR), Garrison LP Jr. (AUTHOR)
Publikováno v:
Health Affairs. Mar/Apr2006, Vol. 25 Issue 2, p491-500. 10p.
Autor:
Towse A (AUTHOR), Garrison LP Jr (AUTHOR), Towse, Adrian1 (AUTHOR), Garrison, Louis P Jr (AUTHOR)
Publikováno v:
PharmacoEconomics. 2010, Vol. 28 Issue 2, p93-102. 10p.
Autor:
Garrison LP Jr (AUTHOR), Mansley EC (AUTHOR), Abbott TA 3rd (AUTHOR), Bresnahan BW (AUTHOR), Hay JW (AUTHOR), Smeeding J (AUTHOR)
Publikováno v:
Value in Health. Jan/Feb2010, Vol. 13 Issue 1, p8-13. 6p.
Autor:
Olivença F; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Diaz J; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Ramagopalan SV; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK., Garrison LP Jr; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2024 Oct; Vol. 13 (10), pp. e240105. Date of Electronic Publication: 2024 Sep 10.
Autor:
Ramagopalan SV; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK., Gomes M; Department of Applied Health Research, University College London, London, WC1E 6BT, UK., Durand-Zaleski I; AP-HP Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, 75004, France., Malcolm B; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Diaz J; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Mitchell G; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Pearson-Stuttard J; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Garrison LP Jr; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195, USA.
Publikováno v:
Journal of comparative effectiveness research [J Comp Eff Res] 2024 Sep; Vol. 13 (9), pp. e240083. Date of Electronic Publication: 2024 Jul 19.
Autor:
Boustani M; Division of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, IN, USA., Doty EG; Lilly Corporate Center, Indianapolis, IN, 46285, USA., Garrison LP Jr; Department of Pharmacy, The CHOICE Institute, University of Washington, Seattle, WA, USA., Smolen LJ; Medical Decision Modeling Inc, Indianapolis, IN, USA., Klein TM; Medical Decision Modeling Inc, Indianapolis, IN, USA., Murphy DR; Medical Decision Modeling Inc, Indianapolis, IN, USA., Spargo AW; Lilly Corporate Center, Indianapolis, IN, 46285, USA., Belger M; Eli Lilly and Company, Bracknell, UK., Johnston JA; Lilly Corporate Center, Indianapolis, IN, 46285, USA. johnston_joseph_a@lilly.com.
Publikováno v:
Neurology and therapy [Neurol Ther] 2024 Dec; Vol. 13 (6), pp. 1641-1659. Date of Electronic Publication: 2024 Sep 18.
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US Oncologists.
Autor:
Li M; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. Electronic address: meng.li@tuftsmedicalcenter.org., Elsisi Z; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA, USA., Wong W; Genentech, Inc, South San Francisco, CA, USA., Kowal S; Genentech, Inc, South San Francisco, CA, USA., Veenstra DL; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA, USA., Garrison LP Jr; The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.
Autor:
Garrison LP Jr; VeriTech Corporation, Mercer Island, WA, USA; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA. Electronic address: lgarrisn@uw.edu., Jiao B; VeriTech Corporation, Mercer Island, WA, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Elsisi Z; VeriTech Corporation, Mercer Island, WA, USA; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA., Yehoshua A; Gilead Sciences, Inc Foster City, CA, USA., Koruth R; Gilead Sciences, Inc Foster City, CA, USA., Kreter B; Gilead Sciences, Inc Foster City, CA, USA., Grueger J; The Comparative Health Outcomes, Policy, and Economics Institute, University of Washington, Seattle, WA, USA; Boston Consulting Group Zurich, Healthcare Practice Area, Zurich, Switzerland.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Aug; Vol. 27 (8), pp. 1021-1029. Date of Electronic Publication: 2024 Apr 23.
Autor:
Jiao B; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA; Department of Global Health and Population, Havard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: bjiao@hsph.harvard.edu., Carlson JJ; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA., Garrison LP Jr; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA., Basu A; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Apr; Vol. 27 (4), pp. 433-440. Date of Electronic Publication: 2024 Jan 06.
Autor:
Buck PO; Moderna Inc., Cambridge, MA 02139, USA., Gomes DA; Analysis Group, Inc., Menlo Park, CA 94025, USA., Beck E; Moderna Inc., Cambridge, MA 02139, USA., Kirson N; Analysis Group, Inc., Boston, MA 02199, USA., Mattera M; Analysis Group, Inc., New York City, NY 10036, USA., Carroll S; Moderna Inc., London SW1E 6DE, UK., Ultsch B; Moderna Germany GmbH, 81671 München, Germany., Jayasundara K; Moderna Inc., Toronto, ON M5V 0C3, Canada., Uhart M; Moderna Inc., 75007 Paris, France., Garrison LP Jr; School of Pharmacy, University of Washington, Seattle, WA 98195, USA.; Global Health Economics LLC, Mercer Island, WA 98040, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Feb 24; Vol. 12 (3). Date of Electronic Publication: 2024 Feb 24.